Macropinocytosis As a Means of Selectively Targeting RAS-Mutant Multiple Myeloma

Authors:

Abstract
Disclosures. Ramirez:TEZCAT Biosciences: Current Employment; IllumaRas: Current holder of stock options in a privately-held company, Membership on an entity's B